Kehrel B, Kronenberg A, Rauterberg J, Niesing-Bresch D, Niehues U, Kardoeus J, Schwippert B, Tschöpe D, van de Loo J, Clemetson K J
Department of Internal Medicine, University of Münster, Germany.
Blood. 1993 Dec 1;82(11):3364-70.
The aggregation of platelets induced by collagens is considered an important step in primary hemostasis. Glycoprotein (GP) IIIb (GPIIIb, GPIV, CD36) has been proposed as a blood platelet receptor for collagen. Platelets from three healthy blood donors were shown to be clearly deficient in GPIIIb. These platelets aggregated normally in response to type I and III collagens. In addition, platelet factor 4, beta-thromboglobulin, and adenosine triphosphate (ATP) secretion in response to type I and III collagens was normal. The findings indicate that GPIIIb is not the major, essential collagen receptor for type I and III collagens. This would explain why all individuals with GPIIIb-deficient platelets examined so far are healthy and, in particular, show no apparent evidence of hemostatic problems. However, in contrast to control platelets, no aggregation and impaired platelet factor 4, beta-thromboglobulin, and ATP secretion was observed in response to type V collagen. Therefore, it is postulated that for type V collagen-induced aggregation both GPIa/IIa and GPIIIb are essential.
胶原蛋白诱导的血小板聚集被认为是初级止血过程中的一个重要步骤。糖蛋白(GP)IIIb(GPIIIb、GPIV、CD36)被认为是胶原蛋白的血小板受体。来自三名健康献血者的血小板显示出明显的GPIIIb缺陷。这些血小板对I型和III型胶原蛋白的反应正常聚集。此外,血小板因子4、β-血小板球蛋白和三磷酸腺苷(ATP)对I型和III型胶原蛋白的分泌正常。研究结果表明,GPIIIb不是I型和III型胶原蛋白的主要必需胶原蛋白受体。这就解释了为什么到目前为止所有接受检查的GPIIIb缺陷血小板个体都是健康的,特别是没有明显的止血问题迹象。然而,与对照血小板相比,对V型胶原蛋白的反应未观察到聚集,血小板因子4、β-血小板球蛋白和ATP分泌受损。因此,推测对于V型胶原蛋白诱导的聚集,GPIa/IIa和GPIIIb都是必需的。